Compare ClearPoint Neuro Inc (CLPT) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ClearPoint Neuro Inc vs 10X Genomics Inc — how do they compare? ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M), while 10X Genomics Inc trades at $59 (market cap $7.61B). The key difference: 10X Genomics Inc is far larger — about 16.8× ClearPoint Neuro Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | TXG | |
|---|---|---|
Market Cap | $454.21M | $7.61B |
Sector | Health | Health |
52-Week High | $29.60 | $58.57 |
52-Week Low | $8.66 | $11.34 |
Enterprise Value | $488.79M | $7.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
